Transcriptomics and experiments verified that astaxanthin reduces the apoptosis of nerve cells in ischemic stroke by inhibiting the toll-like receptor signaling pathway
Ontology highlight
ABSTRACT: Background and Objective. Inflammation is an important pathological process in ischemic stroke (IS). Astaxanthin (ATX) is a natural product with neuroprotection effects. However, the mechanism of ATX on anti-inflammatory after IS is not clear. The aim of this study was to investigate the mechanism of ATX on anti-inflammatory after IS. Methods. Male Sprague-Dawley rats were used to establish a model of middle cerebral artery occlusion (MCAO) on one side, and were pre-treated with gavage of ATX for 7 days. One day after MCAO, the brain tissues were collected. Transcriptomic sequencing, flow cytometry, brain water content, western blot, HE staining and ELISA were analyzed to evaluated the brain damage. Results. ATX treatment has improved the neurological deficits, reduced brain edema, and apoptosis. Also, ATX has reduced inflammation and apoptosis related proteins such as TLR4, MyD88, NFκB, IL1β, IL6, Cyt C and Caspsae3. Conclusions. ATX can improve nerve damage after IS, and these protective effects were realized by anti-inflammatory and anti-apoptosis. This protective mechanism involves the TLR4/MyD88/NF-κB signaling pathway
ORGANISM(S): Rattus norvegicus
PROVIDER: GSE324069 | GEO | 2026/03/10
REPOSITORIES: GEO
ACCESS DATA